A Network Meta-Analysis of the Dose-Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes.

Front Endocrinol (Lausanne) · 2022 · PMC9301373 · PMID 35872994

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly significantno p-value reported

There was a slightly significant difference in the occurrence of urinary tract infection between dapagliflozin 10 mg and insulin alone (OR = 0.74, 95% CI: 0.57 to 0.96).

also in 1,756 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.